This Week in Hearing

Installing Auracast in a public venue is one thing. Making sure people with hearing loss can actually use it effectively is another. Reporting live from the GN Hearing booth at EUHA 2026, Andrew Bellavia speaks with Laurel Christensen, Chief Audiology Officer at GN Hearing; Alastair Moore, Technology Lead at RNID; and Gideon Hoffman, an experienced hearing technology user, about the

Gene therapy is opening new possibilities for addressing the underlying causes of genetic hearing loss. Brian Taylor, AuD, is joined by Jodi Cook, PhD, CEO of Skylark Bio, and Alexa Kozak, AuD, to discuss emerging therapeutic interventions for inherited hearing loss, with a particular focus on GJB2-related hearing loss, commonly associated with the connexin 26 protein. They explain the role

How do audiologists decide which hearing aids to recommend to their patients? And how much of that decision is guided by scientific evidence versus clinical experience, patient listening needs, and traditional technology-tiering approaches? In this conversation, host Brian Taylor is joined by Rachael Pennock, AuD, a PhD student at Northwestern University, to discuss her recently published research examining how audiologists

Starkey’s new Omega AI+ hearing aids introduce a Quad DNN processing architecture, enhanced speech-in-noise technology, improved feedback management, and new sleep-tracking capabilities. But what do these advancements mean for hearing aid users and hearing care professionals? Reporting from Starkey Day in Minneapolis, Andrew Bellavia speaks with three of Starkey’s senior leaders to explore the technology behind Omega AI+ and the

Nearly half (48%) of U.S. adults say society doesn’t know enough about hearing loss — even though people overwhelmingly recognize the importance of good hearing. In this conversation, Shari Eberts speaks with Dr. Patrick D’Haese, Corporate Director of Awareness and Public Affairs at MED-EL, about findings from a new international survey of more than 10,000 adults across 10 countries. The

Hearing loss often develops gradually, which means many people may not recognize changes until they begin interfering with everyday communication. A new national initiative is looking to change that by making hearing screening a routine part of healthy aging. Shari Eberts is joined by Dr. Jill Davis, President of the Academy of Doctors of Audiology (ADA), and Mike O’Neil, U.S.

Oticon’s new Reveal hearing aid platform introduces a Dual AI approach designed to manage speech and contextual sounds while preserving the broader sound environment around the listener. Andrew Bellavia visits the Oticon Reveal U.S. launch at OticonNext in San Diego for an in-depth look at the technology with Michael Lamberson, President of Oticon USA, and Thomas Behrens, Vice President of

Pediatric cochlear implant candidacy has expanded significantly in recent years, creating opportunities for earlier intervention and opening the door to implantation for children who may not have been considered candidates in the past. Dr. Bob Traynor is joined by Dr. Samantha Scharf, Research Assistant Professor in the Department of Otolaryngology/Head and Neck Surgery at the University of North Carolina at

For people with hearing loss, many of the biggest challenges happen outside the clinic—from navigating difficult listening situations to managing the emotional and social impact of hearing loss. Shari Eberts is joined by Dan Reiner, Director of Communications and Marketing at the Hearing Loss Association of America (HLAA), to explore how the organization can complement clinical hearing care and help

Fortell is taking an unusual path for a hearing aid startup: entering the prescription hearing aid market with proprietary AI technology, its own clinics, and a care model built around audiologists. Shari Eberts speaks with Fortell co-founders Matt de Jonge and Cole Morris about the company’s approach to one of the most persistent challenges in hearing care—understanding speech in environments